Volume 20, Number 2—February 2014
Research
Monitoring Human Babesiosis Emergence through Vector Surveillance New England, USA
Table 3
Data source, y | Lyme disease† | Babesiosis† | Human ratio‡ | B. burgdorferi§ | B. microti§ | Tick ratio¶ | Human/tick ratio |
---|---|---|---|---|---|---|---|
Private practice | |||||||
Nantucket, 2010 | 7,500 | 1,250 | 6.0 | 0.21 | 0.09 | 2.33 | 2.6 |
Northeastern CT, 2010 |
660 |
70 |
9.4 |
0.26 |
0.05 |
5.20 |
1.8 |
Reported to CT DPH or MA DPH | |||||||
Nantucket, 2010 | 194 | 56 | 3.5 | 0.21 | 0.09 | 2.33 | 1.5 |
Northeastern CT, 2010 | 211 | 7 | 30.0 | 0.26 | 0.05 | 5.20 | 5.8 |
Southeastern CT, 2007 | 191 | 85 | 2.3 | 0.15 | 0.17 | 0.88 | 2.6 |
*CT DPH, Connecticut Department of Public Health; MA DPH, Massachusetts Department of Public Health.
†Annual incidence rates of Lyme disease and human babesiosis calculated for the towns and years for which tick assessments were conducted by using private practice or state-reported cases and mid-year population estimates from CT DPH (23) and MA DPH (24).
‡Ratio of human Lyme disease incidence rates to babesiosis incidence rates.
§Nymphal Ixodes scapularis tick infection prevalence with Borrelia burgdorferi and Babesia microti.
¶ Ratio of I. scapularis ticks infection prevalence with B. burgdorferi and infection prevalence with B. microti.
Page created: January 17, 2014
Page updated: January 17, 2014
Page reviewed: January 17, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.